Do you want to read an article? Please log in or register.
Global perspectives on the provision of diabetic retinopathy screening and treatment: Survey of health care professionals in 41 countries
Diabetes - General
Related content
Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings
Ophthalmology.
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, Maia M, Mathenge W, Moreker S, Muqit MMK, Resnikoff S, Verdaguer J, Zhao P, Ferris F, Aiello LP, Taylor HR
doi: 10.1016/j.ophtha.
Diabetes - General
Adult care providers' perspectives on the transition to adult care for emerging adults with Type 1 diabetes: a cross-sectional survey
Diabet Med.
Michaud S, Dasgupta K, Bell L, Yale JF, Anjachak N, Wafa S, Nakhla M
doi: 10.1111/dme.13627.
Implementation and Evaluation of a Large-Scale Teleretinal Diabetic Retinopathy Screening Program in the Los Angeles County Department of Health Services
JAMA Intern Med.
Daskivich LP, Vasquez C, Martinez C Jr, Tseng CH, Mangione CM
doi: 10.1001/
Diabetic ComplicationsPediatric Diabetes
Vulnerabilities in diabetic eye screening for children and young people in England
Pediatr Diabetes.
Ibanez-Bruron MC, Solebo AL, Cumberland PM, Rahi JS, Diabetic Eye Disease in Childhood Study (DECS) group.
doi: 10.1111/pedi.12887.
Diabetes - GeneralDiabetic Complications
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
Diabetologia.
Eleuteri A, Fisher AC, Broadbent DM, García-Fiñana M, Cheyne CP, Wang A, Stratton IM, Gabbay M, Seddon D, Harding SP; Individualised Screening for Diabetic Retinopathy (ISDR) Study Group
doi: 10.1007/
COMMENTED
Diabetes - General
Professional Practice Committee: Standards of Medical Care in Diabetes—2018
Diabetes Care.
2018 Jan.
41(Supplement 1): S3-S3.
doi: 10.2337/dc18-Sppc01.
doi: 10.2337/dc18-Sppc01.
Diabetes - GeneralDiabetic Complications
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Diabetes Care.
Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW
doi: 10.2337/dc16-2641.
COMMENTED
Type 2 Diabetes
Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Griffin SJ, Rutten GEHM, Khunti K, Witte DR, Lauritzen T, Sharp SJ, Dalsgaard EM, Davies MJ, Irving GJ, Vos RC, Webb DR, Wareham NJ, Sandbæk A
doi: 10.1016/S2213-8587(19)30349-3.
COMMENTED
Diabetes - General
Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus
Ann Intern Med.
Roglic G, Norris SL
doi: 10.7326/M18-1149.